Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £20.17m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

Update regarding NPXe plc

28 May 2019 07:00

RNS Number : 2195A
Inspiration Healthcare Group PLC
28 May 2019
 

28 May 2019

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", or the "Company") 

 

Update regarding NPXe plc

(formerly Neuroprotexeon Limited)

 

Inspiration Healthcare Group plc (AIM:IHC), the global medical technology company notes that further to the statement made on 7 December 2018 regarding the potential IPO of NPXe plc, it has recently been informed that NPXe plc is no longer looking to IPO in the UK but is pursuing a private offering in the USA, which will be conducted under US securities law. 

 

UK Investors remain able to participate in this private offering which is eligible for EIS/VCT relief and should contact NPXe plc directly should they wish to do so. Further announcements will be made should the Company be made aware of material developments. 

 

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Mike Briant, Chief Financial Officer

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Cameron MacRitchie

Tel: 0207 397 8900

 

Cadogan PR

Alex Walters

Tel: 07771 713608

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies. 

 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

 

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

 

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

 

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDQDLFLKEFFBBD
Date   Source Headline
25th Oct 202110:15 amRNSReplacement: Director/PDMR Shareholding
22nd Oct 20214:35 pmRNSDirector/PDMR Shareholding
20th Oct 20215:02 pmRNSDirector/PDMR Shareholding
5th Oct 20217:00 amRNSInterim Results
4th Oct 20217:00 amRNSTR1 Notification
24th Sep 20217:00 amRNSNotice of Results, Mello and AIM Awards
11th Aug 20217:00 amRNSTrading Update
27th Jul 202110:13 amRNSDirector/PDMR Shareholding
12th Jul 20217:00 amRNSTR1 Notification
25th Jun 202112:43 pmRNSResult of AGM
25th Jun 20217:00 amRNSAGM Statement
23rd Jun 20211:15 pmRNSAGM Notice
22nd Jun 20217:00 amRNSProject WAVE recruits first patient
16th Jun 20219:18 amRNSDirector/PDMR Shareholding
16th Jun 20217:00 amRNSCapital Markets Day
28th May 20217:00 amRNSAnnual Report 2021 and Notice of AGM
20th May 20212:15 pmRNSMello Healthcare Presentation 25th May 2021
17th May 20217:00 amRNS£1.25m Ventilator Order received from China
29th Apr 20217:00 amRNSQueen’s Award for Enterprise for SLE Ltd
29th Apr 20217:00 amRNSTR1 Notification
27th Apr 20217:00 amRNSFinal Results
21st Apr 20217:00 amRNSSLE 6000 & OxyGenie® China approval &250k Order
19th Apr 20215:30 pmRNSTR1 Notification
19th Apr 20215:30 pmRNSTR1 Notification
19th Apr 20215:30 pmRNSTR1 Notification
29th Mar 20217:00 amRNSDistribution Agreement and MoU
16th Mar 20217:00 amRNSSLE 6000 & OxyGenie® Japan approval & £400k Order
23rd Feb 20212:10 pmRNSSecond Price Monitoring Extn
23rd Feb 20212:01 pmRNSPrice Monitoring Extension
23rd Feb 202111:06 amRNSSecond Price Monitoring Extn
23rd Feb 202111:01 amRNSPrice Monitoring Extension
18th Feb 20217:00 amRNSResults date and post period end update
15th Feb 20214:41 pmRNSSecond Price Monitoring Extn
15th Feb 20214:36 pmRNSPrice Monitoring Extension
15th Feb 20212:06 pmRNSSecond Price Monitoring Extn
15th Feb 20212:00 pmRNSPrice Monitoring Extension
15th Feb 202111:06 amRNSSecond Price Monitoring Extn
15th Feb 202111:01 amRNSPrice Monitoring Extension
15th Feb 20219:06 amRNSSecond Price Monitoring Extn
15th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20212:06 pmRNSSecond Price Monitoring Extn
11th Feb 20212:01 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSRevenue and Profit Upgrade
21st Jan 20217:00 amRNSExercise of options and Total Voting Rights
14th Jan 20217:00 amRNSTR1 Notification
2nd Dec 20207:00 amRNSEuropean Patent granted for Project WAVE
1st Dec 20201:16 pmRNSInspiration wins AIM Transaction of the Year Award
16th Nov 20207:00 amRNSProject WAVE MHRA Approval
29th Oct 20207:00 amRNSAppointment of Non-Executive Director
6th Oct 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.